Introduction {#Sec1}
============

Berberine (C~20~H~18~NO~4~) is an isoquinoline alkaloid belonging to the protoberberine alkaloids. It was first discovered by Buchner and Herberger in 1830, and the structure is shown in Fig. [1](#Fig1){ref-type="fig"}. Berberine is widely and extensively distributed in the roots, rhizomes and stems of plants of the Euphorbiaceae, Ranunculaceae and Papaveraceae families \[[@CR1]--[@CR3]\]. Among them, the main plants that contain berberine are *Coptidis rhizoma* (Huanglian in Chinese), Barberry (*Berberis vulgaris* L.) and *Scutellaria baicalensis*, which have been used as traditional folk medicines in China, India, Iran and other countries \[[@CR4], [@CR5]\]. Because berberine is the most studied among the protoberberine alkaloids in nature, it has a longer history of application \[[@CR6]\]. In the early 1960s, Indian researchers demonstrated that berberine and its salts, such as berberine sulfate, are valuable for the treatment of cholera, severe diarrhoea and amoebiasis \[[@CR7], [@CR8]\]. At the end of the twentieth century, researchers conducted clinical research and developed berberine for the treatment of diarrhoea associated with various bacteria \[[@CR9], [@CR10]\]. So far, the pharmacological activity of berberine has been related to almost all disorders of the body, such as cardiovascular disease (e.g., antiarrhythmia and vasodilation) \[[@CR11], [@CR12]\], blood disease and cancer \[[@CR13], [@CR14]\], immune system diseases \[[@CR15]\], and central nervous system diseases \[[@CR16]\]. Because of its effectiveness, especially in the treatment of diarrhoea, berberine has become an essential medicine for every family in China.Fig. 1The structure of berberine

From this point of view, the study of the pharmacological effects of berberine is important and challenging. Currently, most reviews on the pharmacological effects of berberine have just summarized the data or provided a retrospective analysis of limited articles \[[@CR17], [@CR18]\]. These reviews did not expand on topics such as the relationship of berberine's research members or its evolution in the field of pharmacology, and they did not failed to provide information about key authors, institutions, or literature in the field. Hence, a review of the current literature on berberine would require a great deal of time for a beginner; there is no summary of the current research focus, and there are no predictions of the frontiers in this field. However, it is crucial for researchers to guide studies and improve their efficiency. Therefore, solving this series of problems is very important and essential.

Bibliometrics is a comprehensive analytical method for quantifying the content of literature, and it was first defined by Pritchard in 1969 \[[@CR19]\]. Bibliometrics is based on analysing the features of the literature, such as the types, journals, and authors, to study the distribution structures, quantitative relationships, law changes and quantitative management and to explore the structures and characteristics of scientific technology using mathematical, statistical and other measurement methods. The application of bibliometrics is very extensive. Micro-applications include identifying the core literature in specific areas, showing academic journal progress and so forth \[[@CR20]\], while macro-applications have included improving the processing efficiency of information, predicting trends in discipline development and so on \[[@CR21]\]. Hence, this study uses bibliometrics and visual analysis tools to analyse the knowledge base and development of berberine pharmacological studies by analysing countries, organizations, authors, journals, topics, keywords and other features of the related literature, which could provide a broad perspective for learning about the hotspots and frontiers of this field.

Data collection and analysis {#Sec2}
============================

Data collection and screening {#Sec3}
-----------------------------

The data for this study were collected from the Web of Science core database. The selected time was from 1985 to 2018. The database was searched using the terms "berberine", "berberine" and "pharmacology", and "berberine" and "pharmacological", which identified 5106, 46, and 357 articles, respectively. Subsequently, the articles were conditionally screened and merged, and duplicates were removed. A total of 1426 compliant publications were found. The specific process is shown in Fig. [2](#Fig2){ref-type="fig"}.Fig. 2Research flow chart of the study

Application software {#Sec4}
--------------------

To assist the analysis and to display the data visually, we used Histcite, CiteSpace, the bibliometrix R-package and other applications. Histcite is a powerful citation analysis tool developed by SCI's inventor Eugene Garfield \[[@CR22]\]. The knowledge visualization software of CiteSpace is one of the most popular tools for drawing scientific knowledge maps. It was developed by Professor Chen Chaomei of the Drexel University Department of Computer and Information Science. CiteSpace can measure and analyse documents in specific fields and reflect the objective situation of scientific development \[[@CR23]--[@CR25]\]. Bibliometrix is an R-tool that enables data processing, analysis and visualization \[[@CR26]\].

Analysis results and discussions {#Sec5}
================================

General statistics {#Sec6}
------------------

By statistically analysing the overall situation of the berberine pharmacological field and the variations in the quantity of publications over time, we can effectively evaluate the historical development process and the current research state and predict the future trends in development.

We counted the categories and literature types from 1985 to 2018. A total of 1426 studies were collected for bibliographic records. The research articles we found were from 69 countries/regions, 1381 institutions, 5675 authors, and 325 journals; they contained 3794 key words; they were written in 7 languages; and they were of 2 article types. We counted the number of publications and determined the global citation scores for each year from 1985 to 2018, as shown in Fig. [3](#Fig3){ref-type="fig"}. Overall, the number of publications has increased exponentially over time. At the same time, the changes in the total global citation score (TGCS) have been unstable. First, there was relatively flat growth for 20 years and then a rapid growth period from 2005 to 2012. There were two peaks during this period, 2009 and 2012. Subsequently, the overall trend was a rapid decrease. Through careful analysis of the data, we found that the number of articles in 2009 was small, but the TGCS was high because most of the article scores were higher, indicating that 2009 was a key year in the field. There were several articles with scores greater than 150, which were related to the effects of berberine on Alzheimer's disease and as an antioxidant and anticancer therapy \[[@CR27], [@CR28]\], and they were classic literature for the topic. The decline is likely to be due to a lack of more new research in the newer papers. Of the 1426 studies, from an analysis of the document types, there were 1286 (90.18%) articles and 140 (9.82%) reviews; from an analysis of the document language, the majority were in English (98.74%), Chinese (11, 0.77%), Japanese (3, 0.21%), and Polish, Spanish, German, or Italian (each 1, 0.07%).Fig. 3Yearly output and score

Country/region characteristics {#Sec7}
------------------------------

Statistics on the research countries and regions of berberine pharmacology publications can clearly illustrate the status of the development of berberine pharmacology in each country and facilitate comparisons. Between 1985 and 2018, a total of 69 countries/regions conducted studies related to the field of berberine pharmacology. Figures [4](#Fig4){ref-type="fig"} and [5](#Fig5){ref-type="fig"} shows the global distribution of the studies and list the percentages of studies in the top ten countries over the years. In the 34 years from 1985 to 2018, Asia, Western Europe and North America were relatively active in this field. Among them, China had the largest number of published studies, 795, accounting for 55.75% of the total. Berberine is derived from the traditional Chinese medicine Huanglian, *Phellodendron* and so forth and is widely used in China. Easy access to the original plants, ancient book records, the obvious therapeutic effects, and significant need have greatly promoted the enthusiasm of Chinese research on berberine. The USA and South Korea are the second and third countries, respectively, with the greatest number of published studies on berberine. The average global citation score \[TGCS/records\] of the USA is 35.33, which is 13.40 higher than China's score of 21.93. On the basis of this indicator, China's score in this area is relatively low. From the changes in the number of studies in various countries over the years, it can be seen that the number of countries in early research on berberine is relatively small and that there are comparatively many Asian regions.Fig. 4Distribution of global publications in the field of berberine pharmacology Fig. 5The percentage of articles in the top ten countries

Scientific cooperation analysis {#Sec8}
-------------------------------

The scientologists Katz and Martin define scientific cooperation as follows: scientific cooperation is the study of scholars working together for the common purpose of producing new scientific knowledge \[[@CR29]\]. Since the 20th century, the pattern of multiple authors in the literature has grown linearly. Big data show that collaborative papers from multiple researchers can produce more influential articles \[[@CR30]\]. Figure [6](#Fig6){ref-type="fig"}a--c shows the respective partnerships among countries, institutions, and authors. Obviously, partnerships exist between countries, of which China and the United States have the most exchanges and cooperation, but most partnerships are mainly domestic communications. Due to the large number of institutions and authors, we selected the top 90 for visual display. Institutions and authors cluster according to the strength and number of partnerships. Different categories are represented by different colours. Overall, the two networks are relatively connected, therefore the communication of knowledge and information in the network is smooth between the institutions and authors, which can promote the rapid development of the field. However, cooperation is also affected by geography and other factors; there are some isolated institutions, such as Jinan University. In addition, 77 of the top 90 research institutions are universities and constitute the main body. Then, there are 8 research units and 5 hospitals. The field is also mainly based on basic research, and the cooperation model is not sufficiently complete.Fig. 6Map of cooperative networks among countries, researchers and institutions. **a** Academic cooperation networks between countries/regions. **b** Academic cooperation networks between authors. **c** Academic cooperation networks between institutions

Contributions of institutions and authors {#Sec9}
-----------------------------------------

A total of 1221 institutions and 4963 authors participated in publications in the field of berberine pharmacology. Table [1](#Tab1){ref-type="table"} lists the top 10 institutions in the number of publications and the TGCS. Due to the juxtaposition, a total of 21 pieces of information involve 17 institutions.Table 1The top 10 institutions (based on records and TGCS respectively)InstitutionRecordsInstitutionTGCSChina Pharmaceut Univ71China Pharmaceut Univ1454Chinese Acad Sci34Natl Yang Ming Univ923Shanghai Univ Tradit Chinese Med34China Med Univ763China Med Univ30Seoul Natl Univ732Chinese Acad Med Sci29Univ Macau683Second Mil Med Univ26Univ Hong Kong631Kyung Hee Univ25Kyung Hee Univ627Shenyang Pharmaceut Univ25Panjab Univ580Beijing Univ Chinese Med24Shanghai Univ Tradit Chinese Med575Nanjing Univ Chinese Med24Shanghai Jiao Tong Univ563Chinese Univ Hong Kong563

Table [2](#Tab2){ref-type="table"} is the top 9 authors listed by ranking according to the H-index. The H-index is a mixed quantitative indicator that includes the number of posts and the minimum number of citations and can identify influential authors \[[@CR31]\]. CHEN L is the most influential author, with an H-index of 15 and 21 published articles. Through careful analysis of the data, we find that he has more than 50 references in 7 studies. Due to the low bioavailability and unclear mechanism, whether berberine can treat type 2 diabetes is controversial. CHEN L insisted that berberine can treat type 2 diabetes and launched a series of researches. In recent years, CHEN L focused on the relationship between berberine, type 2 diabetes, and AMPK, which is one of the hot topics in pharmacological research.Table 2The top 9 authorsNameInstitutionH-indexG-indexRecordsTGCSChen LSun Yat-Sen University152121467Wang YShenyang Pharmaceutical University132029450Zhang YJilin University121724331Wang GJChina Pharmaceutical University121616665Ma YMShanghai University of Traditional Chinese Medicine111720301Li XGSouthwest University111515323Liu XDChina Pharmaceutical University111212533Li JChina Pharmaceutical University101620286Ye XLSouthwest University101313285

Performance of journals {#Sec10}
-----------------------

There were 1426 studies on berberine in 325 different journals. Table [3](#Tab3){ref-type="table"} lists the top 10 journals in the berberine literature, containing 35.2% of the total publications. In addition to the relatively low impact factor of BIOLOGICAL & PHARMACEUTICAL BULLETIN, the IFs of the remaining journals are approximately 3.4. As the number one journal for berberine publications, the JOURNAL OF ETHNOPHARMACOLOGY has a TGCS of 2816, which is very high. In this journal, publications with relevant content were published almost every year from 1996 to 2018. In addition, the journals ranked 1, 2, 3, 7, 9, and 10 come from the same publisher, Elsevier.Table 3The top 10 journalsRankJournalISSNRecsTGCSIF (2018)1*Journal of Ethnopharmacology*0378--87418228163.4142*European Journal of Pharmacology*0014--29995920883.1703*Journal of Pharmaceutical And Biomedical Analysis*0731--70855614832.9834*Phytotherapy Research*0951--418X4915453.7665*Planta Medica*0032--09434914312.7466*Biological & Pharmaceutical Bulletin*0918--61584817301.5407*Phytomedicine*0944--71134713034.1808*Acta Pharmacologica Sinica*1671--4083459244.0109*Biomedicine & Pharmacotherapy*0753--3322343443.74310*Fitoterapia*0367--326X338692.431

Knowledge base {#Sec11}
--------------

In 1973, the American intelligence scientist Small first proposed the concept of co-citation; that is, when two \[or more\] papers are cited by one or more subsequent papers, we say that the papers have a co-cited relationship. The analysis of co-citation is a research method for measuring the degree of relationship between documents. Co-citation analysis is one of the most commonly used methods in scientific, quantitative research \[[@CR24]\]. Clustering analysis is an exploratory data mining technology used to ultimately obtain several structured clusters to discover the topic distribution and organizational structure in the knowledge domain \[[@CR32]\]. First, the relationship strength between two publications is determined by analysing the extent of co-citations in the literature. Then, clustered according to the extent of the co-citation, clusters of the same type of article can be identified. As a consequence, the evolutionary process of a scientific publication will be better understood and key articles in the field can be determined.

### Developments in the field {#Sec12}

Figure [7](#Fig7){ref-type="fig"} shows the timeline view of the co-citation clusters of the top 30 documents each year. Each horizontal line is in chronological order from left to right. The right side is the corresponding clustering label based on the topic or keyword algorithm, and the number of publications included decreases from top to bottom. Each circle represents a publication. Circles with larger radii represent publications with higher citation frequencies, and warmer colours indicate later publication dates. The lines between the circles represent the co-citation relationship. The network has 364 nodes and 841 edges. Modularity Q is 0.6869, which is greater than 0.3, indicating that the structure of the cluster is significant. A silhouette value greater than 0.5 indicates reasonable clustering, and a value greater than 0.7 indicates a well-matched degree of clustering. In the 12 clustered silhouettes, except for cluster 1, which is 0.66, the values are greater than 0.7. The specific information for the 12 clusters is shown in Table [4](#Tab4){ref-type="table"}.Fig. 7Timeline view for document co-citation clusters Table 4The specific situation of 12 clustersCluster IDSizeSilhouetteMean yearCluster label0460.7472008Gata1460.662007Pharmacokinetics2440.7932000Coralyne3310.9411995Antipyretic4310.8672014Pi3k-akt5300.7882006Reactive oxygen species6240.8392008Erk signaling pathway7230.8172012Neuroinflammation8170.8132003Vascular smooth muscle cell9140.9032010Hypoglycemic10100.8891999Therapeutic effect1180.9341997Superoxide dismutase

These 12 clusters represent different topics. From Fig. [7](#Fig7){ref-type="fig"} and Table [4](#Tab4){ref-type="table"}, we can clearly see the development of different topics over time and across the publication of the literature. Early studies included the terms antipyretic, superoxide dismutase, coralyne, therapeutic effect, etc. The antipyretic effects of plants with berberine as a main component have been well recorded; therefore, these effects have been studied since early times. However, it is obvious that the number of documents that are very relevant to this topic in recent years has been small, indicating that researchers might be conducting more research on new effects. Mid-term studies include the terms gata, pharmacokinetics, reactive oxygen species, and vascular smooth muscle cell. At this stage, the overall development of berberine pharmacology is faster. Gata and pharmacokinetics are important research topics that contain a large number of documents and are frequently cited. Although pharmacokinetics is in the mid-term, there have still been some published studies recently, indicating that the duration is long and important. The terms pi3k-akt and neuroinflammation constitute emerging themes in the literature that could continue to evolve.

### Key articles {#Sec13}

Using the co-citation strength as an indicator, we selected the largest coverage value from each category as the key document for the cluster topic. The specific information of the 12 publications is shown in Table [5](#Tab5){ref-type="table"}. Most of the literature has a large TGCS, and this aspect can also indicate the importance of the publication. The coverage and TGCS of the publication "A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species" are large. This article demonstrates that berberine has an inhibitory effect on inflammation through a variety of in vivo models, and that it has a dose-dependent antinociceptive activity that induces gastric damage.Table 5Key articles in each clusterClusterCoverageTGCSTitleFirst authorJournalYear01434Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro studyLIU, L*Naunyn-Schmiedebergs Archives of Pharmacology*201011317Pharrnacokinetic properties, potential herb-drug interactions and acute toxicity of oral rhizoma coptidis alkaloidsMA, BL*Expert Opinion on Drug Metabolism & Toxicology*201321030Protoberberine alkaloids: physicochemical and nucleic acid binding properties., V10, P55 10.1007/7081_2007_071MAITI, M*Bioactive Heterocycles IV Topics in Heterocyclic Chemistry*200735226A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of turkish berberis speciesKUPELI, E*Life Sciences*2002494Identification of actin as a direct proteomic target of berberine using an affinity-based chemical probe and elucidation of its modulatory role in actin assemblyYI, CM*Chemical Communications*20175713Selective regulation of multidrug resistance protein in vascular smooth muscle cells by the isoquinoline alkaloid coptisineSUZUKI, H*Biological & Pharmaceutical Bulletin*20106728Involvement of mitochondrial and b-raf/erk signaling pathways in berberine-induced apoptosis in human melanoma cellsBURGEIRO, A*Anti-Cancer Drugs*20117923Role of berberine in alzheimer's diseaseCAI, ZY*Neuropsychiatric Disease and Treatment*201685121Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1 beta and inducible nitric oxide synthase in the rat model of alzheimer's diseaseZHU, FQ*BMC Neuroscience*20069580Berberine, a plant alkaloid with lipid- and glucose-lowering properties: from in vitro evidence to clinical studiesPIRILLO, A*Atherosclerosis*201510710Blockade of l-type calcium channel in myocardium and calcium-induced contractions of vascular smooth muscle by cpu 86017DAI, DZ*Acta Pharmacologica Sinica*200411354Coptidis rhizoma: protective effects against peroxynitrite-induced oxidative damage and elucidation of its active componentsYOKOZAWA, T*Journal of Pharmacy and Pharmacology*2004

Research hotspots and frontiers {#Sec14}
-------------------------------

Research hotspots can reflect the focus and trends of research, and research frontiers can represent the current state of mind in a research field. Word frequency analysis is a commonly used weighting technique that can be used for information retrieval and text mining to assess the importance of a word in a particular field \[[@CR33]\]. The higher that the frequency is with which a word appears in a file, the greater that its importance is. Therefore, we can reflect the research hotspots of the subject by detecting the frequency of keywords. Burst detection is a technique that can detect dramatic changes in events through algorithms and can be performed in CiteSpace \[[@CR34]\]. It has two attributes: the strength and duration of the burst \[[@CR35]\]. Burst keywords have surged over a period of time, and it can reflect that people's degree of attention to the corresponding event or field has greatly increased during this period of time. Therefore, burst keywords can be used as indicators of emerging trends and predict the development trend to a certain extent \[[@CR36]\].

### Research hotspots {#Sec15}

The frequency of the occurrence of the keywords of the 1426 publications was analysed. The word cloud of the top 50 keywords is shown in Fig. [8](#Fig8){ref-type="fig"}. Keywords with a higher frequency are shown in a larger font. We subjectively divided these words into three categories: the properties of berberine,; experimental and instrument related; and active effect word sets. The attribute word set mostly includes the basic structural features of berberine, such as isoquinoline alkaloids. The experimental and instrument-related word set shows that the experimental subjects are mostly mice and cells, and performance liquid chromatography and tandem mass spectrometry are used most frequently. The active effect word set can be divided mainly into mechanisms and diseases, such as the NF-kappa-b pathway, oxidative stress, anti-inflammatory and obesity.Fig. 8Word cloud of the top 50 words

### Research frontiers {#Sec16}

The length and intensity of the twelve burst words \[coptis chinensis, natural product, Alzheimer's disease, metabolic syndrome, AMPK, obesity, antioxidant, macrophage, up regulation, oxidative stress, autophagy, and inflammation\] are shown in Fig. [9](#Fig9){ref-type="fig"}. This figure indicates that the aspects to which these words belong are still the hotspots and frontiers of research in the pharmacology of berberine in the future. The most intense one is AMPK, the value of which is 7.2003 and it is confirmed related to metabolism. As the number of patients with metabolic diseases continues to rise, it is essential to find a way to treat this diseases. And current research shows that berberine can play an important role in the treatment of nonalcoholic fatty liver through its anti-inflammatory mechanisms and in metabolism by inducing the activation of the AMPK pathway \[[@CR37]--[@CR40]\]. So it can be speculated that this will be one of the focus of future development.Fig. 9The words from the burst detection

Clinical application and mechanism of berberine {#Sec17}
-----------------------------------------------

Through rapid analysis and the tracking of the key literature and cluster analysis information above, we sorted out the main clinical applications and corresponding mechanisms of berberine, as shown in Table [6](#Tab6){ref-type="table"}.Table 6Main clinical application and mechanism of berberineClinical applicationMechanismLiteratureAnti-diarrhealAntibacterial (e.g., Vibrio cholerae)Inhibition of intestinal smooth muscle movementregulates intestinal motilityInhibition of intestinal mucosa K+'s influxrestores intestinal barrier function\[[@CR10], [@CR41]--[@CR44]\]Anticancer(cancer arising from leucocytes, liver, lung, stomach, colon, skin, oral, etc.)Chemical carcinogenic protectionIndependent of the mevalonate pathwayDirectly induces apoptosisDownregulation of nuclear transcription factorsExertion of indirect effectsSuppression of DNA\[[@CR45]--[@CR54]\]Anti-diabeticStimulation of AMPK activity and might inhibit PPARγ activityPromotion of the proliferation of 3T3-L1 pre-adipocytes, reduced lipid accumulation, and inhibition of their differentiationInsulinotropic effectsGood action for lipid metabolismTargeting of non-coding RNAsPromotion the expression of GLUT1Modulation of the gut microbiota\[[@CR55]--[@CR61]\]Anti-cardiovascular(e.g., Atherosclerosis)Inhibition of the expression of LOX-1 through ET-1 receptorsImpacts on potassium ion channels (K +)Increased NO and cGMP contentBlockage of K + channels sensitive to ATP and voltageInhibition of mitogen-activated kinase/extracellular signals\[[@CR62]--[@CR65]\]Anti-inflammatory and immune regulation(e.g., ulcerative colitis)Inhibit cox-2, AP-1 bindingDownregulation of activation of ERK 1/2 and p38 signallings pathways,Inhibition of the production of pro-inflammatory factorsDownregulation of p-ERK, p-p38, and p-JNK activationInhibition of the expression of monocyte chemoattractant protein 1 and cytokine-induced neutrophil chemoattractant 1 induced by lipopolysaccharideInhibition of RNA virus reverse transcriptase activityInhibition of the synthesis of anti-SRBC antibodiesReduced content of PGF2a in inflammatory tissues\[[@CR66]--[@CR72]\]Antipsychotic(e.g., depression, Alzheimer's,)Increased NE and 5-HT concentrations in the brainPromotion of axon extension and axon regeneration in PNS-damaged nervesIncreased expression of BDNF mRNA in the hippocampusActions on the pathological process of amyloid Aβ, inhibitings glial proliferationInhibition of tau hyperphosphorylation induced by calmodulin A and its induced cytotoxicityInhibition of MAO activity\[[@CR73]--[@CR78]\]

We hope that readers become more familiar with berberine. At the same time, it was found that after the analysis of bibliometric methods, the information retrieval and arrangement were more convenient.

Conclusion {#Sec18}
==========

We conducted a bibliometric analysis of 1426 publications on berberine pharmacology published in the Web of Science core database from 1985 to 2018 using big data analysis and visualization software.

Between 1985 and 2018, the number of articles published in the field of berberine pharmacology increased exponentially. More than half of the articles were published in China, but the average TGCS of each article was slightly lower. China Pharmaceutical University is at the centre of academic cooperation, with its number of publications and TGCS being ranked first, and it has three influential scholars: Wang, Liu and Li. These factors fully illustrate the key position of China Pharmaceutical University in the field of berberine pharmacology. Because he has the largest H-index, Chen of Sun Yat-Sen University is the most influential author. The *Journal of Ethnopharmacology* is the journal with the largest number of publications and the highest TGCS. By tracking important institutions, authors, and journals, researchers can quickly understand the state of research in this area.

Through co-citation and cluster analysis, an evolutionary network based on scientific publications was finally formed. There were 12 cluster topics from 1985 to 2018. In the mid-term phase, the field developed rapidly and has gradually moved to more in-depth areas, such as reactive oxygen species and signalling pathways, combined with popular disciplines such as pharmacokinetics. In recent years, researchers have discovered more modern applications of berberine and have also conducted more research on pathways and targets. Based on word frequency and burst detection, we found that metabolic diseases, central nervous system diseases, AMPK, the NF-kappa-b signalling pathway and oxidative stress are the frontiers and hotspots and could become the key development direction in the future.

The research still has limitations, the research limitation of the article is that collected data is not completed enough. To improve the quality of the article, only articles and reviews were selected as the research object, so some important research results might has been missed. In subsequent research, we will further optimize the data source and data screening to improve the quality of the overall data analysis and prediction.

The results of this study demonstrate the evolutionary process and development trends of berberine pharmacology and could enable researchers to quickly understand the key information in the field of berberine pharmacology, to grasp research directions and to improve research efficiency.
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